The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis

BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) are important options for managing rheumatoid arthritis (RA). Once patients achieve disease control, clinicians may consider dose reduction or withdrawal of the bDMARD. Results from published studies indicate that some patients wil...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arthritis Res Ther
Autori principali: Tanaka, Yoshiya, Smolen, Josef S., Jones, Heather, Szumski, Annette, Marshall, Lisa, Emery, Paul
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6610967/
https://ncbi.nlm.nih.gov/pubmed/31277720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1937-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi